APO-Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Tillgänglig från:

Arrotex Pharmaceuticals Pty Ltd

INN (International namn):

pemetrexed disodium hemipentahydrate

Läkemedelsform:

Injection, powder for

Sammansättning:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; mannitol

Administreringssätt:

Intravenous Infusion

Enheter i paketet:

1

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Produktsammanfattning:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Bemyndigande status:

Registered

Tillstånd datum:

2014-09-04